{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T19:36:54Z","timestamp":1789414614573,"version":"build-2803163510"},"reference-count":38,"publisher":"MDPI AG","issue":"22","license":[{"start":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T00:00:00Z","timestamp":1762905600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"University of Oradea","award":["Cercetare Stiintifica UO"],"award-info":[{"award-number":["Cercetare Stiintifica UO"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diagnostics"],"abstract":"<jats:p>Background: The introduction of the \u201ctrace\u201d category in the Xpert MTB\/RIF Ultra assay has significantly improved the sensitivity of molecular tuberculosis diagnostics. While it enhances sensitivity, especially in paucibacillary and extrapulmonary cases, its specificity remains debatable, making its interpretation outside select populations a topic of clinical uncertainty. Objectives: This study evaluates the diagnostic and clinical significance of trace-positive results obtained with the Xpert MTB\/RIF Ultra assay in the context of a high-incidence TB setting, examining their association with clinical, imaging, and microbiological findings. Methods: A retrospective analysis was conducted on 65 samples with trace-positive Xpert Ultra results, collected over a six-year period from 59 distinct patients in a general hospital in Romania. Correlations were assessed with microscopy, culture, clinical features, imaging, treatment initiation, and prior TB history. A composite reference standard was used for diagnostic accuracy evaluation. Results: Of the 65 trace-positive samples, 29 (44.6%) were culture-positive and 5 (7.7%) were smear-positive. A high proportion of patients, 56 (94.9%), presented with TB-compatible symptoms, and 47 (79.6% of those with imaging) had highly suggestive radiological findings. Based on the composite reference standard, 47 patients (79.7%) were ultimately diagnosed with active TB. Anti-TB treatment was initiated in 44 patients (74.5%). Trace positivity was observed across various specimen types, including sputum, pleural fluid, and cerebrospinal fluid. Conclusions: In high TB burden environments, trace-positive Xpert Ultra results frequently reflect true disease when interpreted within the appropriate clinical and imaging framework. Our findings indicate that, in regions with high tuberculosis incidence such as Romania, trace-positive Xpert Ultra results may contribute meaningfully to clinical decision-making when interpreted alongside clinical and radiological findings, in alignment with current WHO guidance.<\/jats:p>","DOI":"10.3390\/diagnostics15222860","type":"journal-article","created":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T08:58:47Z","timestamp":1762937927000},"page":"2860","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Clinical Relevance of Trace-Positive Results in Xpert MTB\/RIF Ultra for Tuberculosis Diagnosis in a High-Burden Setting: A Retrospective Cohort Study"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6456-5770","authenticated-orcid":false,"given":"Cristian","family":"Sava","sequence":"first","affiliation":[{"name":"Department of Medical Disciplines, Faculty of Medicine and Pharmacy, University of Oradea, 410073 Oradea, Romania"},{"name":"Bihor County Clinical Emergency Hospital, 410167 Oradea, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2463-8100","authenticated-orcid":false,"given":"Alin","family":"Iuhas","sequence":"additional","affiliation":[{"name":"Department of Medical Disciplines, Faculty of Medicine and Pharmacy, University of Oradea, 410073 Oradea, Romania"},{"name":"Bihor County Clinical Emergency Hospital, 410167 Oradea, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristian","family":"Marin\u0103u","sequence":"additional","affiliation":[{"name":"Department of Medical Disciplines, Faculty of Medicine and Pharmacy, University of Oradea, 410073 Oradea, Romania"},{"name":"Bihor County Clinical Emergency Hospital, 410167 Oradea, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4165-8816","authenticated-orcid":false,"given":"Radu","family":"Gali\u0219","sequence":"additional","affiliation":[{"name":"Department of Medical Disciplines, Faculty of Medicine and Pharmacy, University of Oradea, 410073 Oradea, Romania"},{"name":"Bihor County Clinical Emergency Hospital, 410167 Oradea, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4526-9076","authenticated-orcid":false,"given":"Marius","family":"Rus","sequence":"additional","affiliation":[{"name":"Department of Medical Disciplines, Faculty of Medicine and Pharmacy, University of Oradea, 410073 Oradea, Romania"},{"name":"Bihor County Clinical Emergency Hospital, 410167 Oradea, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mihaela","family":"Sava","sequence":"additional","affiliation":[{"name":"Bihor County Clinical Emergency Hospital, 410167 Oradea, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,11,12]]},"reference":[{"key":"ref_1","unstructured":"(2024). Global Tuberculosis Report 2024, World Health Organization. [1st ed.]."},{"key":"ref_2","unstructured":"Tuberculosis Incidence (per 100 000 Population per Year). Available online: https:\/\/www.who.int\/data\/gho\/data\/indicators\/indicator-details\/GHO\/incidence-of-tuberculosis-(per-100-000-population-per-year)."},{"key":"ref_3","unstructured":"European Centre for Disease Prevention and Control, and World Health Organization (2024). Tuberculosis Surveillance and Monitoring in Europe 2024: 2022 Data, Publications Office."},{"key":"ref_4","unstructured":"WHO Operational Handbook on Tuberculosis (2024). Module 3: Diagnosis-Rapid Diagnostics for Tuberculosis Detection, World Health Organization. [3rd ed.]."},{"key":"ref_5","unstructured":"World Health Organization (2025). WHO Consolidated Guidelines on Tuberculosis. Module 3: Diagnosis. Web Annex B. Evidence Synthesis and Analysis, World Health Organization."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"E00560-18","DOI":"10.1128\/JCM.00560-18","article-title":"Performance of Xpert MTB\/RIF, Xpert Ultra, and Abbott RealTime MTB for Diagnosis of Pulmonary Tuberculosis in a High-HIV-Burden Setting","volume":"56","author":"Berhanu","year":"2018","journal-title":"J. Clin. Microbiol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"e00949-22","DOI":"10.1128\/spectrum.00949-22","article-title":"The Practical Value of Xpert MTB\/RIF Ultra for Diagnosis of Pulmonary Tuberculosis in a High Tuberculosis Burden Setting: A Prospective Multicenter Diagnostic Accuracy Study","volume":"10","author":"Wang","year":"2022","journal-title":"Microbiol. Spectr."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Iuhas, A., Jurca, C., Kozma, K., Riza, A.-L., Strea\u021b\u0103, I., Petche\u0219i, C., Dan, A., Sava, C., Balmo\u0219, A., and Marin\u0103u, C. (2023). PAH Pathogenic Variants and Clinical Correlations in a Group of Hyperphenylalaninemia Patients from North-Western Romania. Diagnostics, 13.","DOI":"10.3390\/diagnostics13081483"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"2813","DOI":"10.21873\/invivo.13019","article-title":"Biomarker Changes in Pediatric Patients With COVID-19: A Retrospective Study from a Single Center Database","volume":"36","author":"Sava","year":"2022","journal-title":"In Vivo"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"e002624","DOI":"10.1136\/bmjresp-2024-002624","article-title":"Real-World Clinical Utility of Xpert MTB\/RIF Ultra in the Assessment of Tuberculosis in a Low-TB-Incidence, High-Resource Setting","volume":"12","author":"Kim","year":"2025","journal-title":"BMJ Open Respir. Res."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Sava, C., Sava, M., Dr\u0103gan, A.-M., Iuhas, A., Niula\u0219, L., Marin\u0103u, C., and Balmo\u0219, A. (2023). The Use of Xpert MTB\/RIF Ultra Testing for Early Diagnosis of Tuberculosis: A Retrospective Study from a Single-Center Database. Genes, 14.","DOI":"10.3390\/genes14061231"},{"key":"ref_12","unstructured":"World Health Organization (2014). Xpert MTB\/RIF Implementation Manual: Technical and Operational \u2018How-to\u2019Practical Considerations, World Health Organization."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1016\/j.cmi.2019.03.021","article-title":"The Rapid Molecular Test Xpert MTB\/RIF Ultra: Towards Improved Tuberculosis Diagnosis and Rifampicin Resistance Detection","volume":"25","author":"Opota","year":"2019","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_14","unstructured":"WHO (2017). WHO Meeting Report of a Technical Expert Consultation Non-Inferiority Analysis of Xpert MTFRIF Ultra Compared to Xpert, World Health Organization."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Andama, A., Jaganath, D., Crowder, R., Asege, L., Nakaye, M., Katumba, D., Mukwatamundu, J., Mwebe, S., Semitala, C.F., and Worodria, W. (2021). The Transition to Xpert MTB\/RIF Ultra: Diagnostic Accuracy for Pulmonary Tuberculosis in Kampala, Uganda. BMC Infect. Dis., 21.","DOI":"10.1186\/s12879-020-05727-8"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Guillouzouic, A., Gaudart, A., Tessier, E., Risso, K., Hamdad, F., Alauzet, C., Vaillant, P., Koebel, C., Kassegne, L., and Chenouard, R. (2023). Xpert MTB\/RIF Ultra Trace Results: Decision Support for the Treatment of Extrapulmonary Tuberculosis in Low TB Burden Countries. J. Clin. Med., 12.","DOI":"10.3390\/jcm12093148"},{"key":"ref_17","first-page":"CD013359","article-title":"Xpert MTB\/RIF and Xpert MTB\/RIF Ultra Assays for Active Tuberculosis and Rifampicin Resistance in Children","volume":"2020","author":"Kay","year":"2020","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"e12","DOI":"10.1590\/s1678-9946202264012","article-title":"Gene-Xpert Ultra for the Diagnosis of Extrapulmonary Tuberculosis in Children and Adolescents","volume":"64","author":"Aurilio","year":"2022","journal-title":"Rev. Inst. Med. Trop. S\u00e3o Paulo"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1111\/pai.13637","article-title":"Diagnostic Accuracy of Xpert Ultra for Childhood Tuberculosis: A Preliminary Systematic Review and Meta-analysis","volume":"33","author":"Signorino","year":"2022","journal-title":"Pediatr. Allergy Immunol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1007\/s44197-023-00150-z","article-title":"Evaluation of Xpert MTB\/RIF Ultra for the Diagnosis of Extrapulmonary Tuberculosis: A Retrospective Analysis in Saudi Arabia","volume":"13","author":"Slail","year":"2023","journal-title":"J. Epidemiol. Glob. Health"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/S1473-3099(17)30691-6","article-title":"Xpert MTB\/RIF Ultra for Detection of Mycobacterium Tuberculosis and Rifampicin Resistance: A Prospective Multicentre Diagnostic Accuracy Study","volume":"18","author":"Dorman","year":"2018","journal-title":"Lancet Infect. Dis."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/S1473-3099(17)30474-7","article-title":"Diagnostic Accuracy of Xpert MTB\/RIF Ultra for Tuberculous Meningitis in HIV-Infected Adults: A Prospective Cohort Study","volume":"18","author":"Bahr","year":"2018","journal-title":"Lancet Infect. Dis."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1093\/cid\/ciad595","article-title":"Evidence for Tuberculosis in Individuals With Xpert Ultra \u201cTrace\u201d Sputum During Screening of High-Burden Communities","volume":"78","author":"Sung","year":"2024","journal-title":"Clin. Infect. Dis."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"e00812-17","DOI":"10.1128\/mBio.00812-17","article-title":"The New Xpert MTB\/RIF Ultra: Improving Detection of Mycobacterium Tuberculosis and Resistance to Rifampin in an Assay Suitable for Point-of-Care Testing","volume":"8","author":"Chakravorty","year":"2017","journal-title":"mBio"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.ijid.2021.10.056","article-title":"Tracing TB: Are There Predictors for Active TB Disease in Patients with Xpert Ultra Trace Results?","volume":"114","author":"Dowling","year":"2022","journal-title":"Int. J. Infect. Dis."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"96","DOI":"10.4103\/japt.japt_39_23","article-title":"Evaluation of the Prevalence of Xpert Ultra Trace Calls and Its Clinical Significance in Pulmonary and Extrapulmonary Tuberculosis in High Tuberculosis-Endemic Setting","volume":"6","author":"Prakash","year":"2023","journal-title":"J. Assoc. Pulmonologist Tamil Nadu"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.47363\/JPRR\/2024(6)163","article-title":"Xpert MTB\/RIF Ultra-Trace Call Results and Pathways for TB Treatment","volume":"6","author":"Muhammad","year":"2024","journal-title":"J. Pulmonol. Res. Rep."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Van Dinh, L., Tran, K.T., Codlin, A.J., Vo, L.N.Q., Nguyen, N.T.T., Nguyen, L.P., Forse, R., Nguyen, H.T., Dang, T.M.H., and Nguyen, L.H. (2025). Prevalence of Xpert MTB\/RIF Ultra Trace Call Results and Associated Risk Factors During Active Tuberculosis Case Finding in Viet Nam: A Programmatic Evaluation. Diagnostics, 15.","DOI":"10.3390\/diagnostics15081006"},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Iuhas, A., Marin\u0103u, C., Niula\u0219, L., Futaki, Z., Balmo\u0219, A., Kozma, K., Indrie\u0219, M., and Sava, C. (2024). Familial Mediterranean Fever in Romania: A Case Report and Literature Review. Front. Pediatr., 12.","DOI":"10.3389\/fped.2024.1546387"},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Marin\u0103u, C., Csep, A., Sava, C., Iuhas, A., Niula\u0219, L., Szilagyi, A., Ritli, L., Balmo\u0219, A., and Jurca, C. (2023). Difficulties in the Management of an Askin Tumor in a Pediatric Patient with Cystic Fibrosis: Case Report and Literature Review. Front. Pediatr., 11.","DOI":"10.3389\/fped.2023.1289256"},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Galis, R., Trif, P., Mudura, D., Murvai, R., Daina, L.G., Szasz, F., Negrini, R., Hatos, A., Gyarmati, B.F., and Daly, M.C. (2024). Preterm Birth and Stillbirth during COVID-19 Pandemic in Bihor County\/Romania. Front. Reprod. Health, 6.","DOI":"10.3389\/frph.2024.1286496"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.ejcdt.2013.09.014","article-title":"Is a Composite Reference Standard (CRS) an Alternative to Culture in Assessment and Validation of a Single Tube Nested in-House PCR for TB Diagnosis?","volume":"62","author":"Deshmukh","year":"2013","journal-title":"Egypt. J. Chest Dis. Tuberc."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"j5779","DOI":"10.1136\/bmj.j5779","article-title":"Concerns about Composite Reference Standards in Diagnostic Research","volume":"360","author":"Dendukuri","year":"2018","journal-title":"BMJ"},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Chen, X., Fan, Y., Tu, H., and Luo, Y. (2025). Clinical Efficacy of Different Therapeutic Options for Knee Osteoarthritis: A Network Meta-Analysis Based on Randomized Clinical Trials. PLoS ONE, 20.","DOI":"10.1371\/journal.pone.0324864"},{"key":"ref_35","first-page":"CD009593","article-title":"Xpert Ultra versus Xpert MTB\/RIF for Pulmonary Tuberculosis and Rifampicin Resistance in Adults with Presumptive Pulmonary Tuberculosis","volume":"2","author":"Zifodya","year":"2021","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.pulmoe.2022.01.011","article-title":"Nontuberculous Mycobacteria in Portugal: Trends from the Last Decade","volume":"30","author":"Santos","year":"2024","journal-title":"Pulmonology"},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Atherton, R.R., Cresswell, F.V., Ellis, J., Kitaka, S.B., and Boulware, D.R. (2019). Xpert MTB\/RIF Ultra for Tuberculosis Testing in Children: A Mini-Review and Commentary. Front. Pediatr., 7.","DOI":"10.3389\/fped.2019.00034"},{"key":"ref_38","first-page":"102478","article-title":"Xpert MTB\/RIF Ultra for the Rapid Diagnosis of Extrapulmonary Tuberculosis in a Clinical Setting of High Tuberculosis Prevalence Country and Interpretation of \u201ctrace\u201d Results","volume":"145","author":"Nasrin","year":"2024","journal-title":"Tuberc. Edinb. Scotl."}],"container-title":["Diagnostics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-4418\/15\/22\/2860\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T09:00:55Z","timestamp":1762938055000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-4418\/15\/22\/2860"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,12]]},"references-count":38,"journal-issue":{"issue":"22","published-online":{"date-parts":[[2025,11]]}},"alternative-id":["diagnostics15222860"],"URL":"https:\/\/doi.org\/10.3390\/diagnostics15222860","relation":{},"ISSN":["2075-4418"],"issn-type":[{"value":"2075-4418","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,12]]}}}